We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 8,551 results
  1. Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation

    A distinct profile of NRAS mutants is observed in each tumor type. It is unclear whether these profiles are determined by mutagenic events or...

    Brandon M. Murphy, Elizabeth M. Terrell, ... Christin E. Burd in Nature Communications
    Article Open access 07 June 2022
  2. Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis

    Preventing or effectively treating metastatic uveal melanoma (UM) is critical because it occurs in about half of patients and confers a very poor...

    Jackson R. Richards, Donghan Shin, ... Jae Hyuk Yoo in Oncogene
    Article 27 July 2023
  3. RNF8 enhances the sensitivity of PD-L1 inhibitor against melanoma through ubiquitination of galectin-3 in stroma

    The failure of melanoma immunotherapy can be mediated by immunosuppression in the tumor microenvironment (TME), and insufficient activation of...

    Yanan Guo, Rong Shen, ... Degui Wang in Cell Death Discovery
    Article Open access 30 June 2023
  4. Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy

    Epacadostat (EPA), the most advanced IDO1 inhibitor, in combination with PD-1 checkpoint inhibitor, has failed in a recent Phase III clinical trial...

    Zhiren Wang, Wenpan Li, ... Jianqin Lu in Nature Communications
    Article Open access 09 November 2023
  5. SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation

    Melanoma is the most lethal type of skin cancer, originating from the malignant transformation of melanocyte. While the development of targeted...

    **uli Yi, Huina Wang, ... Chunying Li in Signal Transduction and Targeted Therapy
    Article Open access 15 March 2023
  6. Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance

    Melanoma cells exhibit phenotypic plasticity that allows transition from a proliferative and differentiated phenotype to a more invasive and...

    Mithalesh K. Singh, Sarah Altameemi, ... Vijayasaradhi Setaluri in Scientific Reports
    Article Open access 23 August 2022
  7. Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition

    Immunotherapies, including immune checkpoint inhibitors, have limitations in their effective treatment of malignancies. The immunosuppressive...

    Bandar Alharbi, Husam Qanash, ... Steven G. Gray in Scientific Reports
    Article Open access 08 May 2023
  8. Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells

    The protocadherin proteins are cell adhesion molecules at the crossroad of signaling pathways playing a major role in neuronal development. It is now...

    Arnaud Carrier, Cécile Desjobert, ... Joëlle Riond in Clinical Epigenetics
    Article Open access 28 November 2022
  9. Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma

    Multi-omics profiling by CITE-seq bridges the RNA-protein gap in single-cell analysis but has been largely applied to liquid biopsies. Applying...

    Ulrike Lischetti, Aizhan Tastanova, ... Mitchell P. Levesque in Communications Biology
    Article Open access 10 August 2023
  10. Multi-modal molecular programs regulate melanoma cell state

    Melanoma cells display distinct intrinsic phenotypic states. Here, we seek to characterize the molecular regulation of these states using multi-omic...

    Miles C. Andrews, Junna Oba, ... Scott E. Woodman in Nature Communications
    Article Open access 09 July 2022
  11. VEGF-A promotes the motility of human melanoma cells through the VEGFR1–PI3K/Akt signaling pathway

    Vascular endothelial growth factor A (VEGF-A) and its receptors (VEGFR1 and R2) play important roles in the progression of malignant melanoma through...

    Koichi Koizumi, Tomoaki Shintani, ... Tetsuji Okamoto in In Vitro Cellular & Developmental Biology - Animal
    Article Open access 23 August 2022
  12. Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy

    Immunotherapy efficacy is limited in melanoma, and combinations of immunotherapies with other modalities have yielded limited improvements but also...

    Daniel K. Lester, Chase Burton, ... Eric K. Lau in Nature Cancer
    Article Open access 23 January 2023
  13. The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

    Finding effective therapeutic targets to treat NRAS-mutated melanoma remains a challenge. Long non-coding RNAs (lncRNAs) recently emerged as...

    Valentin Feichtenschlager, Linan Chen, ... Susana Ortiz-Urda in Molecular Cancer
    Article Open access 22 February 2024
  14. Plectin promotes tumor formation by B16 mouse melanoma cells via regulation of Rous sarcoma oncogene activity

    Background

    Melanoma is a malignant tumor characterized by high proliferation and aggressive metastasis. To address the molecular mechanisms of the...

    Kana Mizuta, Takuma Matsubara, ... Shoichiro Kokabu in BMC Cancer
    Article Open access 30 August 2022
  15. Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein

    Abstract

    Arginine deiminase (ADI) is a microbial-derived enzyme which catalyzes the conversion of l -arginine into l -citrulline. ADI originating from Mycoplasma...

    Haein Lee, Geunhwa Park, ... Tai Hyun Park in Applied Microbiology and Biotechnology
    Article 13 October 2022
  16. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma

    The mitochondrial genome (mtDNA) encodes essential machinery for oxidative phosphorylation and metabolic homeostasis. Tumor mtDNA is among the most...

    Mahnoor Mahmood, Eric Minwei Liu, ... Payam A. Gammage in Nature Cancer
    Article Open access 29 January 2024
  17. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression

    Originally considered to act as a transcriptional co-factor, Pirin has recently been reported to play a role in tumorigenesis and the malignant...

    Cristina Penas, Yoana Arroyo-Berdugo, ... María D. Boyano in Scientific Reports
    Article Open access 12 June 2023
  18. Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients

    Background

    Nivolumab is an anti-PD1 antibody that has dramatically improved metastatic melanoma patients’ outcomes. Nevertheless, many patients are...

    Domenico Galati, Serena Zanotta, ... Paolo A. Ascierto in Journal of Translational Medicine
    Article Open access 11 May 2023
  19. Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model

    Immunotherapy of advanced melanoma has encountered significant hurdles in terms of clinical efficacy. Here, we designed a clinically translatable...

    Alessio Malfanti, Mathilde Bausart, ... Véronique Préat in Drug Delivery and Translational Research
    Article 11 April 2023
  20. Melanoma stem cells promote metastasis via exosomal miR-1268a inactivation of autophagy

    Background

    Metastatic melanoma has a high mortality rate and poor survival. This is associated with efficient metastatic colonization, but the...

    **aoshuang Li, Doudou Liu, ... H. Rosie **ng in Biological Research
    Article Open access 01 October 2022
Did you find what you were looking for? Share feedback.